Institutional Ownership Centessa Pharmaceuticals PLC (CNTA)
This table provides information about the institutional ownership of Centessa Pharmaceuticals PLC (CNTA). We have compiled data on the 118 institutions that hold shares in the stock, with a total of 124 Million shares, which have been reported (via 13F filing form) to have a value of $2.01 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
178,600
shares
|
$2.82 Million
0.0% of portfolio
|
Q4 2024
Reduced 14.79%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
175,566
shares
|
$2.77 Million
0.0% of portfolio
|
Q4 2024
Added 1244.82%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
175,428
shares
|
$2.77 Million
0.0% of portfolio
|
Q4 2024
Reduced 74.26%
|
|
|
High Mark Wealth Management LLC
|
Jan 31, 2025 Q4 2024 |
166,135
shares
|
$2.62 Million
1.61% of portfolio
|
Q4 2024
Reduced 0.6%
|
|
|
J. Goldman & CO LP
New York, NY |
Feb 14, 2025 Q4 2024 |
164,703
shares
|
$2.6 Million
0.08% of portfolio
|
Q4 2024
New holding
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Feb 13, 2025 Q4 2024 |
154,027
shares
|
$2.43 Million
0.52% of portfolio
|
Q4 2024
Added 561.0%
|
|
|
Cutter Capital Management, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
147,076
shares
|
$2.32 Million
1.01% of portfolio
|
Q4 2024
New holding
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
139,732
shares
|
$2.21 Million
0.0% of portfolio
|
Q4 2024
Reduced 22.74%
|
|
|
Exome Asset Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
137,716
shares
|
$2.18 Million
1.73% of portfolio
|
Q4 2024
Reduced 0.32%
|
|
|
Diadema Partners LP
Morristown, NJ |
Feb 14, 2025 Q4 2024 |
131,862
shares
|
$2.08 Million
0.95% of portfolio
|
Q4 2024
New holding
|
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
115,107
shares
|
$1.82 Million
0.0% of portfolio
|
Q4 2024
Added 14.41%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
107,058
shares
|
$1.69 Million
0.0% of portfolio
|
Q4 2024
Added 10.92%
|
|
|
Artia Global Partners LP
Miami, FL |
Feb 14, 2025 Q4 2024 |
80,380
shares
|
$1.27 Million
0.48% of portfolio
|
Q3 2024
New holding
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Feb 13, 2025 Q4 2024 |
79,000
shares
|
$1.25 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Legal & General Group PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
75,451
shares
|
$1.19 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Lazard Asset Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
73,189
shares
|
$1.16 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Gsa Capital Partners LLP
London, X0 |
Feb 07, 2025 Q4 2024 |
71,947
shares
|
$1.14 Million
0.09% of portfolio
|
Q4 2024
Reduced 23.18%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
57,257
shares
|
$904,660
0.0% of portfolio
|
Q4 2024
Added 1.17%
|
|
|
Rtw Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
50,000
shares
|
$790,000
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
48,106
shares
|
$760,074
0.0% of portfolio
|
Q4 2024
Reduced 1.0%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Feb 14, 2025 Q4 2024 |
47,453
shares
|
$749,757
0.22% of portfolio
|
Q4 2024
Reduced 60.57%
|
|
|
High Vista Strategies LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
46,116
shares
|
$728,632
0.32% of portfolio
|
Q3 2024
New holding
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
45,885
shares
|
$724,983
0.01% of portfolio
|
Q4 2024
Reduced 65.79%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
43,708
shares
|
$690,586
0.0% of portfolio
|
Q4 2024
Reduced 86.05%
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
41,900
shares
|
$662,020
0.02% of portfolio
|
Q4 2024
New holding
|